SARS-CoV spike all5KO mutant
(Plasmid
#231921)
-
PurposeFor expression of SARS-CoV spike protein with glycan deletion at N1080, N1116, N1140, N1155, N1176 by implementing Asn-to-Gln mutation
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 231921 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namespike all5KO
-
SpeciesSARS-CoV
-
MutationN1080Q, N1116Q, N1140Q, N1155Q, N1176Q
-
Entrez GeneS (a.k.a. sars2, E2)
- Promoter CMV
-
Tags
/ Fusion Proteins
- CD5 signal peptide (N terminal on insert)
- C9 (C terminal on insert)
Cloning Information
- Cloning method Other
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byFang Li, Plasmid pcDNA3.1-SARS-Spike (Addgene # 145031)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
SARS-CoV spike all5KO mutant was a gift from Sriram Neelamegham (Addgene plasmid # 231921 ; http://n2t.net/addgene:231921 ; RRID:Addgene_231921) -
For your References section:
Conserved role of spike S2 domain N-glycosylation across betacoronaviruses. Yang Q, Kelkar A, Manicassamy B, Neelamegham S. npj Viruses. 2025 Jan; 3(4). doi: 10.1038/s44298-024-00085-7. 10.1038/s44298-024-00085-7